Second Primary Cancers Occurring after I-125 Brachytherapy as Monotherapy for Early Prostate Cancer
- 17 February 2014
- journal article
- Published by Elsevier BV in Clinical Oncology
- Vol. 26 (4), 210-215
- https://doi.org/10.1016/j.clon.2014.01.006
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- International Variation in Prostate Cancer Incidence and Mortality RatesEuropean Urology, 2012
- Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupBJU International, 2012
- Prostate Brachytherapy and Second Primary Cancer Risk: A Competitive Risk AnalysisJournal of Clinical Oncology, 2011
- Second Malignancies after Definitive Radiotherapy for Prostate CancerBrachytherapy, 2010
- Mortality Results from a Randomized Prostate-Cancer Screening TrialThe New England Journal of Medicine, 2009
- Second Primary Cancer After Radiotherapy for Prostate Cancer—A SEER Analysis of Brachytherapy Versus External Beam RadiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Second malignancies after prostate brachytherapy: Incidence of bladder and colorectal cancers in patients with 15 years of potential follow-upInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Cancer incidence after localized therapy for prostate cancerCancer, 2006
- Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate CancerJNCI Journal of the National Cancer Institute, 2003
- Second malignancies in prostate carcinoma patients after radiotherapy compared with surgeryCancer, 2000